Makary remains FDA commissioner through 2026

Market overview

Marty Makary will continue serving as FDA commissioner beyond the current reporting period, despite White House and HHS pressure. His survival is attributed to Trump's indecisiveness and Makary's alignment with administration priorities.

leadership prediction market

Implied probability (Yes)

70%

Source: user-generated

More leadership markets

• Will CFO resign before 2026-12-31? — 40% Yes
• Rep. Edwards resigns from Congress before 2026 midterms — 55% Yes
• Chuck Edwards to resign before Ethics Committee ruling — 70% Yes
• Witkoff Rubio partnership gains influence in Middle East policy by 2027 — 55% Yes
• Edwards resigns from Congress by end of 2028 — 60% Yes
• Trump administration to nominate a more industry-aligned FDA chief by Labor Day — 68% Yes
• NRCC chair calls for town halls ban by 2027 — 60% Yes
• Will CEO Mark Zediker resign before FYE? — 60% Yes

Browse all leadership markets →